Simplifying the preevacuation testing strategy for patients with molar pregnancy

J Reprod Med. 2007 Aug;52(8):685-8.

Abstract

Objective: To review our institution's preevacuation testing strategy for suspected molar pregnancy to determine whether a simplified approach might be indicated.

Study design: Patients diagnosed with molar pregnancy from 1999 to 2004 were identified. Clinical data were retrospectively extracted from medical records.

Results: One hundred fifty-eight women diagnosed (mean age, 24 years) underwent dilatation and curettage. Molar pregnancy was suspected at presentation in 111 (70%); 47 (30%) cases were presumed miscarriages, and the diagnosis was confirmed only after histologic evaluation of the specimen. Initial testing included complete blood count (CBC) (87%), liver function tests (LFT) (63%), thyroid-stimulating hormone (TSH) level (72%), clotting function studies (26%) and chest radiograph (84%). One patient with right upper quadrant pain had elevated LFTs and a coagulopathy that resolved after evacuation. One woman with a palpably enlarged goiter and elevated TSH level was diagnosed with thyroid carcinoma. No chest radiograph demonstrated metastatic disease.

Conclusion: We advocate a simplified approach to preevacuation testing for suspected molar pregnancy that includes a CBC and blood type with antibody screen. Clinical assessment should prompt additional evaluation in the rare patient with suspicious signs and symptoms.

MeSH terms

  • ABO Blood-Group System
  • Abortion, Spontaneous / blood
  • Adolescent
  • Adult
  • Blood Cell Count
  • Chorionic Gonadotropin, beta Subunit, Human / blood
  • Chorionic Gonadotropin, beta Subunit, Human / urine
  • Diagnosis, Differential
  • Female
  • Humans
  • Hydatidiform Mole / diagnosis*
  • Hydatidiform Mole / surgery
  • Liver Function Tests
  • Medical Records
  • Molar
  • Pregnancy
  • Retrospective Studies
  • Uterine Neoplasms / diagnosis*
  • Uterine Neoplasms / surgery
  • Vacuum Curettage / methods

Substances

  • ABO Blood-Group System
  • Chorionic Gonadotropin, beta Subunit, Human